KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enterprise Products Partners (EPD) Cash & Equivalents (2016 - 2025)

Enterprise Products Partners (EPD) has disclosed Cash & Equivalents for 17 consecutive years, with $969.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 66.21% to $969.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $969.0 million through Dec 2025, up 66.21% year-over-year, with the annual reading at $969.0 million for FY2025, 66.21% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $969.0 million at Enterprise Products Partners, up from $226.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $2.2 billion in Q3 2021, with the low at $76.0 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $343.4 million, with a median of $216.2 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents skyrocketed 2138.12% in 2021, then plummeted 92.46% in 2022.
  • Over 5 years, Cash & Equivalents stood at $145.0 million in 2021, then fell by 10.34% to $130.0 million in 2022, then grew by 7.69% to $140.0 million in 2023, then skyrocketed by 316.43% to $583.0 million in 2024, then surged by 66.21% to $969.0 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $969.0 million, $226.0 million, and $226.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.